PCK
Click for more information
7.14% 3.0¢ painchek ltd

PainChek General Discussion, page-13702

  1. Guggsy
    1,136 Posts.
    lightbulb Created with Sketch. 412
    clock Created with Sketch.
    11/04/20
    00:40
    Post #: 43994590

    Top 76 Startups developing health apps



    https://www.medicalstartups.org/top/apps/

    Painchek coming in at no. 41 .

    Huge company in the making

    5million dollars government funding and set to potentially
    increase .
    Great times ahead on many fronts ..
    stay patient investors.

    Enjoy the Easter break. Enjoy some family time .Stay safe and well .

    Guggsy
    PCK Price at posting: 9.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 15  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.0¢ 		Change
0.002(7.14%) 		Mkt cap ! $49.07M
Open High Low Value Volume
2.8¢ 3.0¢ 2.8¢ $9.306K 318.7K

Buyers (Bids)

No. Vol. Price($)
1 43275 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 1255935 2
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.